Betahistine metabolites, Aminoethylpyridine, and Hydroxyethylpyridine increase cochlear blood flow in guinea pigs in vivo

References

• Arpornchayanon W., Canis M., Ihler F., Settevendemie C. & Strieth S. 2013. TNF-alpha inhibition using etanercept prevents noise-induced hearing loss by improvement of cochlear blood flow in vivo. Int J Audiol, 52, 545–552.
   PubMed Web of Science ®Google Scholar
• Baker M. & Wayland H. 1974. On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res, 7, 131–143.
   PubMed Web of Science ®Google Scholar
• Boles R., Rice D.H., Hybels R. & Work W.P. 1975. Conservative management of Ménière's disease: Furstenberg regimen revisited. Ann Otol Rhinol Laryngol, 84, 513–517.
   PubMed Web of Science ®Google Scholar
• Botta L., Mira E., Valli S., Zucca G., Benvenuti C. et al. 2001. Effects of betahistine and of its metabolites on vestibular sensory organs. Acta Otorhinolaryngol Ital, 21, 24–30.
   PubMedGoogle Scholar
• Botta L., Mira E., Valli S., Zucca G., Perin P. et al. 2000. Effects of betahistine metabolites on frog ampullar receptors. Acta Otolaryngol, 120, 25–27.
   PubMed Web of Science ®Google Scholar
• Bowman F.J., Bowman E.R. & McKennis H. Jr. 1972. Possible alternate routes in the metabolism of betahistine in the rabbit. Proc Soc Exp Biol Med, 140, 1385–1388.
   PubMedGoogle Scholar
• Brown J.N. & Nuttall A.L. 1994. Autoregulation of cochlear blood flow in guinea pigs. Am J Physiol, 266, H458–467.
   PubMedGoogle Scholar
• Canis M., Arpornchayanon W., Messmer C., Suckfuell M., Olzowy B. et al. 2010. An animal model for the analysis of cochlear blood flow [corrected] disturbance and hearing threshold in vivo. Eur Arch Otorhinolaryngol, 267, 197–203.
   PubMedGoogle Scholar
• Chen X.Y., Zhong D.F., Duan J.L. & Yan B.X. 2003. LC-MS-MS analysis of 2-pyridylacetic acid, a major metabolite of betahistine: Application to a pharmacokinetic study in healthy volunteers. Xenobiotica, 33, 1261–1271.
   PubMedGoogle Scholar
• Dagli M., Goksu N., Eryilmaz A., Mocan Kuzey G., Bayazit Y. et al. 2008. Expression of histamine receptors (H(1), H(2), and H(3)) in the rabbit endolymphatic sac: An immunohistochemical study. Am J Otolaryngol, 29, 20–23.
   PubMedGoogle Scholar
• Dziadziola J.K., Laurikainen E.L., Rachel J.D. & Quirk W.S. 1999. Betahistine increases vestibular blood flow. Otolaryngol Head Neck Surg, 120, 400–405.
   PubMed Web of Science ®Google Scholar
• Fossati A., Barone D. & Benvenuti C. 2001. Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. Pharmacol Res, 43, 389–392.
   PubMed Web of Science ®Google Scholar
• Gbahou F., Davenas E., Morisset S. & Arrang J.M. 2010. Effects of betahistine at histamine H3 receptors: Mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo. J Pharmacol Exp Ther, 334, 945–954.
   PubMed Web of Science ®Google Scholar
• Goodwin P.C., Miller J.M., Dengerink H.A., Wright J.W. & Axelsson A. 1984. The laser Doppler: A non-invasive measure of cochlear blood flow. Acta Otolaryngol, 98, 403–412.
   PubMed Web of Science ®Google Scholar
• Ihler F., Bertlich M., Sharaf K., Strieth S., Strupp M. et al. 2012. Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo. PLoS One, 7, e39086.
   PubMed Web of Science ®Google Scholar
• Ihler F., Strieth S., Pieri N., Gohring P. & Canis M. 2012. Acute hyperfibrinogenemia impairs cochlear blood flow and hearing function in guinea pigs in vivo. Int J Audiol, 51, 210–215.
   PubMed Web of Science ®Google Scholar
• James A.L. & Burton M.J. 2001. Betahistine for Ménière's disease or syndrome. Cochrane Database Syst Rev, CD001873.
   PubMedGoogle Scholar
• Kawakami M., Makimoto K., Fukuse S. & Takahashi H. 1991. Autoregulation of cochlear blood flow. A comparison of cerebral blood flow with muscular blood flow. Eur Arch Otorhinolaryngol, 248, 471–474.
   PubMed Web of Science ®Google Scholar
• Kimura R.S. 1967. Experimental blockage of the endolymphatic duct and sac and its effect on the inner ear of the guinea pig. A study on endolymphatic hydrops. Ann Otol Rhinol Laryngol, 76, 664–687.
   PubMed Web of Science ®Google Scholar
• Kimura R.S. 1982. Animal models of endolymphatic hydrops. Am J Otolaryngol, 3, 447–451.
   PubMed Web of Science ®Google Scholar
• Klyscz T., Junger M., Jung F. & Zeintl H. 1997. Cap image: A new kind of computer-assisted video image analysis system for dynamic capillary microscopy. Biomed Tech (Berl), 42, 168–175.
   PubMedGoogle Scholar
• Konzett H., Bost R.G., Bowman F.J., Bowman E.R. & McKennis H. Jr. 1971. Betahistine, its metabolites and vascular responses in the forelimb of the dog. J Pharmacol Exp Ther, 178, 122–129.
   PubMedGoogle Scholar
• Lamm K. & Arnold W. 2000. The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2), and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res, 141, 199–219.
   PubMed Web of Science ®Google Scholar
• LaRouere M.J., Sillman J.S., Nuttall A.L. & Miller J.M. 1989. A comparison of laser Doppler and intravital microscopic measures of cochlear blood flow. Otolaryngol Head Neck Surg, 101, 375–384.
   PubMed Web of Science ®Google Scholar
• Laurikainen E., Miller J.F. & Pyykko I. 2000. Betahistine effects on cochlear blood flow: From the laboratory to the clinic. Acta Otolaryngol Suppl, 544, 5–7.
   PubMedGoogle Scholar
• Laurikainen E., Miller J.M., Nuttall A.L. & Quirk W.S. 1998. The vascular mechanism of action of betahistine in the inner ear of the guinea pig. Eur Arch Otorhinolaryngol, 255, 119–123.
   PubMedGoogle Scholar
• Lezius F., Adrion C., Mansmann U., Jahn K. & Strupp M. 2011. High-dosage betahistine dihydrochloride between 288 and 480 mg/day in patients with severe Ménière's disease: A case series. Eur Arch Oto-Rhino-L, 268, 1237–1240.
   PubMed Web of Science ®Google Scholar
• Malinowska B., Godlewski G. & Schlicker E. 1998. Histamine H3 receptors: General characterization and their function in the cardiovascular system. J Physiol Pharmacol, 49, 191–211.
   PubMedGoogle Scholar
• Ménière P. 1861. Congestions cerebrales apoplectiformes. Gaz md Paris, 16, 55.
   Google Scholar
• Meyer P., Schmidt R., Grutzmacher W. & Gehrig W. 1994. Inner ear blood flow with betahistine: An animal experiment study. Laryngorhinootologie, 73, 153–156.
   PubMedGoogle Scholar
• Miller J.M., Goodwin P.C. & Marks N.J. 1984. Inner-ear blood flow measured with a laser Doppler system. Arch Otolaryngol, 110, 305–308.
   PubMedGoogle Scholar
• Miller J.M., Marks N.J. & Goodwin P.C. 1983. Laser Doppler measurements of cochlear blood flow. Hear Res, 11, 385–394.
   PubMed Web of Science ®Google Scholar
• Nakashima T., Suzuki T., Iwagaki T. & Hibi T. 2001. Effects of anterior inferior cerebellar artery occlusion on cochlear blood flow: A comparison between laser-Doppler and microsphere methods. Hear Res, 162, 85–90.
   PubMedGoogle Scholar
• Neuhauser H.K. 2007. Epidemiology of vertigo. Curr Opin Neurol, 20, 40–46.
   PubMed Web of Science ®Google Scholar
• Nuttall A.L. 1987. Techniques for the observation and measurement of red blood cell velocity in vessels of the guinea pig cochlea. Hear Res, 27, 111–119.
   PubMed Web of Science ®Google Scholar
• Pullens B., Giard J.L., Verschuur H.P. & van Benthem P.P. 2010. Surgery for Ménière's disease. Cochrane Db Syst Rev.
   PubMedGoogle Scholar
• Pullens B. & van Benthem P.P. 2011. Intratympanic gentamicin for Ménière's disease or syndrome. Cochrane Db Syst Rev.
   PubMedGoogle Scholar
• Sakai K. 1980. Role of histamine H1-and H2-receptors in the cardiovascular system of the rabbit. J Cardiovasc Pharmacol, 2, 607–617.
   PubMedGoogle Scholar
• Sternson L.A., Tobia A.J., Walsh G.M. & Sternson A.W. 1974. The metabolism of betahistine in the rat. Drug Metab Dispos, 2, 123–128.
   PubMedGoogle Scholar
• Strupp M., Thurtell M.J., Shaikh A.G., Brandt T., Zee D.S. et al. 2011. Pharmacotherapy of vestibular and ocular motor disorders, including nystagmus. J Neurol, 258, 1207–1222.
   PubMed Web of Science ®Google Scholar
• Sun P., Takatori S., Jin X., Koyama T., Tangsucharit P. et al. 2011. Histamine H(3) receptor-mediated modulation of perivascular nerve transmission in rat mesenteric arteries. Eur J Pharmacol, 655, 67–73.
   PubMedGoogle Scholar
• Thirlwall A.S. & Kundu S. 2006. Diuretics for Ménière's disease or syndrome. Cochrane Db Syst Rev.
   PubMedGoogle Scholar
• Val L., Chen L.S., Mendes G.D. & De Nucci G. 2010. Comparative bioavailability of betahistine tablet formulations administered in healthy subjects. Arzneimittelforschung, 60, 440–444.
   PubMedGoogle Scholar
• Woldbaek P.R., Stromme T.A., Sande J.B., Christensen G., Tonnessen T. et al. 2003. Evaluation of a new fiber-optic pressure recording system for cardiovascular measurements in mice. Am J Physiol-Heart C, 285, H2233–H2239.
   Google Scholar
• Wu K.M. & Farrelly J.G. 2007. Regulatory perspectives of Type II prodrug development and time-dependent toxicity management: Nonclinical Pharm/Tox analysis and the role of comparative toxicology. Toxicology, 236, 1–6.
   PubMedGoogle Scholar